EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RISK6 as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk Stratification

Chrispian Mamudi iD, Purnamawati, Panca Andana iD, Prayudi Santoso iD, Lidya Chaidir iD, Arto Soeroto

Pathogens · 2026

DOI: 10.3390/pathogens15050489 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2026. Verfasst von Chrispian Mamudi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Doctoral Program in Medical Science, Faculty of Medicine, Padjadjaran University, Bandung 40161, Indonesia. Hauptthemen laut MEDLINE: Tuberculosis, Transcriptome, Host-Pathogen Interactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) remains a leading cause of infectious mortality worldwide, reflecting persistent gaps in diagnosis, risk stratification, and treatment monitoring. Host RNA transcriptomic signatures have emerged as promising tools for capturing dynamic immune responses across the TB disease spectrum. Among these, the six-gene RISK6 signature has attracted attention due to its parsimonious design and potential for clinical translation. This review provides a clinically oriented synthesis of current evidence on host transcriptomic biomarkers, with a particular focus on the application of RISK6 in diagnosis, prediction of disease progression, and treatment monitoring. Available data suggest that RISK6 demonstrates promising but context-dependent diagnostic performance and represents a versatile host-response biomarker across multiple clinical applications. However, variability across populations and the limited evidence in multidrug-resistant TB remain important constraints. In practice, RISK6 is unlikely to function optimally as a standalone biomarker. Its clinical value appears greater when interpreted within integrated frameworks that combine transcriptomic, microbiological, and clinical data. Further validation in diverse populations and real-world settings will be essential to support meaningful clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TuberculosisTranscriptomeHost-Pathogen InteractionsHumansBiomarkersGene Expression ProfilingRisk AssessmentMycobacterium tuberculosisDisease Progression

Stichwörter der Autor:innen

RISK6diagnosisdisease progressionhost-response biomarkersmultidrug-resistant tuberculosistranscriptomic signaturetreatment monitoringtuberculosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Doctoral Program in Medical Science, Faculty of Medicine, Padjadjaran University, Bandung 40161, Indonesia.
  • Division of Respirology and Critical Care, Department of Internal Medicine, Faculty of Medicine, Krida Wacana Christian University, Jakarta 11510, Indonesia.
  • Department of Histopathology, Faculty of Medicine, Krida Wacana Christian University, Jakarta 11510, Indonesia.
  • Department of Biomedical Sciences, Faculty of Medicine, Padjadjaran University, Bandung 40161, Indonesia.
  • Division of Respirology and Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Padjadjaran University, Bandung 40161, Indonesia.

ORCID-Profile: Chrispian Mamudi, Panca Andana, Prayudi Santoso, Lidya Chaidir

Zitieren

APA

Mamudi, C., Purnamawati, Andana, P., Santoso, P., Chaidir, L., & Soeroto, A. (2026). RISK6 as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk Stratification. Pathogens. https://doi.org/10.3390/pathogens15050489

Vancouver

Mamudi C, Purnamawati, Andana P, Santoso P, Chaidir L, Soeroto A. RISK6 as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk Stratification. Pathogens. 2026. doi:10.3390/pathogens15050489

BibTeX
@article{Mamudi2026,
  author = {Mamudi, Chrispian and Purnamawati and Andana, Panca and Santoso, Prayudi and Chaidir, Lidya and Soeroto, Arto},
  title = {RISK6 as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk Stratification},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15050489}
}
Kostenlos starten →